Bridging the Gap: Index Volume [International Conference on AIDS (12th: 1998: Geneva, Switzerland)]

64 expression* family

12th World AIDS Conference

SKeyword Abstract
mozygosity/Phenotypic expressions of CCR5-A2/A32 homozygo 22415
a-CD4 T-cell response/ Extended benefit of protease inhibitor-con 341*/12101
ted by HIV/Addressing extended life issues among older adults af 13398
immigrants to educate family members and the broader 43185
edication adherence extends to opportunistic infection prophyla 32376
he Uganda experience/ Extension of HIV counselling and testing i 13427
HBV vaccination study. of an ongoing multicenter study 23169
tomegalovirus retinitis/ Extensive optic disc neovascularization in 22273
ne in HIV+ patients with extensive antiviral experience/Effect of ne 12329
each other but not with extra-marital partners/Serodiscordant ma 33268
eletion on cerebral or extracerebral toxoplasmosis occurrence i 13184
e traditional medicine " Extract Spring of Life" - a report of 56 case 60062
e traditional medicine " extract spring of life" (ESOL) -A report of 41238
ARL-1, an polycassine extracted from a kind of plants, Indocalam 41207
a lipid-arabinomannan from Mycobacterium tuberculosi 60313
epidemic of HIV/AIDS/ Extraordinary response from a governme 43219
rats during acute PCP/ Extrapulmonary dissemination of Pneum 31220
-1996/Epidemiology of extrapulmonary tuberculosis among HIV 13269
erved in pulmonary and TB/AIDS patients/Cellul 31206
esting in a country with extremely high HIV prevalence levels/Re 33261
anterior segment of the eye in HIV-infected patients/The viral dise 32245
nts with silicone oil filled eyes and CMV retinitis/Implantation of gan 60786
ucidal properties of the F-5~ gel, a potentially new vaginal microbi 60370,3'-dideoxyadenosine ( F-DDA, lodenosine) in patients with sympt 22281
ailability of lodenosine ( F-ddA ), a uniquely stable anti-HIV drug, in 42263
ide more than a human face /Listening to a patient's perspective m 12457
ase of the center "Faire "/Problematic of a screening center in 33328
th Africa/"Faces" - The of HIV/AIDS in South Africa/"Faces" - 34152
do HIV infected women the social and economic consequenc 34271
Helpline telephone and to face counselling at an AIDS resear 60956
sity hospital/Problems faced during follow-up and treatment of HI 12431
lives: Current problems by HIV-infected physicians/Double I 24304
mbating discrimination by HIV infected at the workplace/Co 44178
ments, to the problems by men having sex with men (MSM)/ 44237
s/challenges/dilemmas by counsellors in HIV/AIDS/Proble 60227
port given to volunteers with a moving illness/Support given 60606
grants/Conducts logics with HIV-AIDS among first- and seco 60943
V/AIDS in South Africa/" Faces "- The face of HIV/AIDS in South Afr 34152
h institution of learning faces as she/he adjusts to meet the deman 33583
eneral public with their uncovered: The experience of U.B.S 43375
Outreach and the many" " of the sex industry in Metro Manila/ 60819
rea infection control/ Facial area infection control/ 60664
s/Indinavir-associated facial atrophy in HIV positive patients/Indi 12391
protocol (GARBTTP) to facilitate access to AIDS prophylactics in d 42320
ng tourist city, hoteliers sex trade/AIDS Outreach Progra 60082
valuation of a gag-pol facilitated DNA vaccine for HIV-1 preventi 33216
ing Group/Community access to free viral load assays: 60699
IV/AIDS) package that facilitates women for better health seekin 13575
time/Computerization clinical decision making by inte 42419
ng to HIV/AIDS in India/ Facilitating strategic planning with NGOs 34149
nnai/Common factors facilitating individuals to have access to S 13482
d as a sustaining and a factor in HIV infection and spre 23470
s future/Designing and empowerment with organized 34171
agnosed in correctional facilities, US, 1993-1996/Characteristics 13265
e/Appropriate hospital for the care of HIV/AIDS patients 22488
t in primary health care in Uganda/Baseline survey of ind 33229
ally funded health care in the United States/Adherence t 42212
aff at juvenile detention towards AIDS prevention progra 43262
ualitative survey of STD in Hanoi, Laocai, Ninhbinh Provin 60307
ce in Liberia: Do health have the capacity?/lmproving HI 60330
ganda/Computerized, facility-based, decentralized reporting sys 34323
ction in a skilled nursing facility /Palliative care for HIV infection in a 505*/22427
tial drug-free treatment in New York City, 1993-1997/Incre 23560
workplace: Outreach to factories in Pathum Thani province, Thaila 13442
tivity in a group of male factory workers in Harare, Zimbabwe/The 13301
eroconversion in a male cohort/Serial CD4 counts followin 13316
xperiences in an urban cohort in Harare, Zimbabwe/Low 22197
d mortality among male workers and their spouses in north 23152
emale partners of male workers in Zimbabwe/High incide 23441
Peer education among workers in Zimbabwe; providing a 540*/33514
us group discussion for workers/Behavior change and livi 33544
ers/Cambodian female garment workers/Cambodian fem 34148
HIV-2 positive mothers fail to develop a BCG scar/HIV negative in 21210

nd itraconazole solution /Treatment of HIV-related oral candido 22218
adherence"/Do people drugs, or do drugs fail people: The disc 638*/34212
y in patients who have failed prior protease inhibitors (PIs): A clini 229*/32287
efficacy among patients failing a delavirdine regimen/Retrospectiv 12236
ng nelfinavir in patients treatment including a protease inhib 12285
n HIV-infected patients to saquinavir therapy: importance o 12306
plasma HIV of patients tritherapy combination/Prevalence 32301

Keyword

Abstract

typing in HIV+ patients protease inhibitor-based highly acti
typing in HIV+ patients highly active antiretroviral therapy (
cue therapy for patients protease inhibitor based therapy/N
nfected adolescent with failure-to-thrive and wasting/Growth hor
entional triple therapy/ Failure of double protease inhibitor therap
r HIV/AIDS prevention: vs. success/Condoms for HIV/AID
IV-infected individuals/ of prophylaxis for Pneumocystis ca
c factors and virological failure /Viral dynamics in HIV infected pati
AART)/Determinants of of highly active antiretroviral therap
ficacy of nelfinavir after of other protease inhibitors (PI)/Lim
e therapy after indinavir /Ritonavir + saquinavir as a rescue t
s salvage therapy after of initial protease inhibitor (PI) regi
wasting syndrome and to thrive among perinatally HIV-infe
dentity and reproductive /Vulnerability to HIV, identity and re
of a multisystem organ (MSOF) score for pneumocystis car
d predictors of virologic of antiretroviral triple drug therapy i
Risk factors for virologic in a cohort of HIV patients receiving
resistance in treatment /Long-term effectiveness of HAAR
herapy for antiretroviral in HIV+ patients/Salvage therapy f
) and acute respiratory (ARF)/Potential role for decision an
/Etiology of acute renal in HIV+ patients/Etiology of acute r
redictor of treatment in high acting antiretroviral therapy (
ollowing initial protease /Long-term viral suppression using
nhibitor after prolonged with indinavir or ritonavir/Salvage t
redictive of therapeutic to d4T/3TC combination/M184V m
rd enough - Virological after 12 months of treatment in ART
ed patients/Virological and adherence to antiretroviral ther
of virological treatment in patients using IDV-containing trip
vir (1592, ABC) in renal /Single-dose plasma profiles of aba
s a prognosis marker of in triple antiretroviral therapies/Rap
and T-cell homeostasis /Changes in markers of T-cell differ
ritherapy including IDV: Results on RNA viral load and CD4

32305
32357
60365
32179
22375
60740
60797
265*/11154
12271
12281
12324
12330
13237
13576
22188
22349
22351
22353
22402
22436
32127
233*/32282
32295
32308
32310
32319
32350
42275
42278
60448
60649
60966

ciated with therapeutic failures in patients on a saquinavir/ritonavi 32294
tection: Successes and /Early HIV detection: Successes a 43104
ence of successes and of HIV prevention in San Francisc 43439
e?/Solutions to system:Abort, retry, ignore?/Solutions to 60131
The case of the center " Faire face"/Problematic of a screening cen 33328
ts in Entebbe, Uganda/ Falciparum malaria and its association wit 130*/22236
n between Plasmodium falciparum malaria illness and HIV-1 RNA 13297
nd macroglobulinemia/ False positive enzyme-linked immunosorb 41168
cal HIV1-transmission/ negative HIV1-PCR in the first two m 42125
ulation on the individual familial and community taking in charge of 33511
g resources available to families affected by HIV/AIDS in northern 12420
in Bangkok - Involving and optimising the use of hospital 67*/22442
grating labour and their /Mobile AIDS booths (MABs) - A 242*/23343
12-25 years) in broken in Yaounde/Street children and A 23431
pact of HIV infection on with one/several infected children 24165
cy planning services for affected by HIV/AIDS: A multi-dis 24209
nd coping strategies of living with TB and AIDS in East Ha 24212
sychological support to of HIV+ children and adolescents 24235
V/AIDS by training their in integral home care (Mexico)/S 260*/24257
ues from providers and /Monitoring treatment adherence i 32438
revention of stresses in of HIV-infected patients/Preventi 261*/33266
anagment of children in affected by HIV/AIDS: Communit 34119
with HIV/AIDS and their in northern Thailand/Community 34167
ected children and their in the Veneto region in Italy/Orga 34314
ith HIV/Stability in with HIV/Stability in 34318
of care for children and affected by HIV/AIDS in Romania 34339
ort for PLWAS and their /ASASSFA's contribution in the pr 34384
iatives on HIV affected /Model for bridging the gap: Unite 44259
d/affected children and /An agenda for a more effective re 44279
e HIV patients and their /Christian psycho-spiritual strateg 60145
AIDS patient/Attitude of towards the death of an AIDS pati 60566
try for women and their /A national Canadian HIV healthli 60669
discplines/Developing family-centred care for HIV/AIDS orphans 24203
S orphans in Zimbabwe/ Family caregivers of AIDS orphans in Zim 24207
ents in rural Zimbabwe/ caregivers of HIV/AIDS patients in r 24319
isions to be HIV tested/, behavioral, and policy factors influ 60778
nfection/The impact of family support on outcome of hospitalizati 74*/12412
ng AIDS prevention into planning program in southern Yunn 360*/13403
/Setting the stage for a intervention: Results from focus gro 235*/13404
S services into existing planning programs/Integrating HIV/ 13572
mportance of social and networks on safer sex practices bas 14177
ual education within the /Mothers role as primary providers o 14335
d HIV infections among blood donors in Karachi, Pakistan/ 23253
es in Nairobi, Kenya/A study among relatives of HIV-1 pers 23354
es in Nairobi, Kenya/A study among relatives of HIV-1 pers 23362
ected by HIV/Trends in structure in African populations affe 24211
AIDS on the household, structure, orphans/Experience in " 24213
f patients HIV positive, and social networks for better assist 24268